PIM1 genetic alterations associated with distinct molecular profiles, phenotypes and drug responses in diffuse large B‐cell lymphoma

PIM1 genetic alterations associated with distinct molecular profiles, phenotypes and drug responses in diffuse large B‐cell lymphoma

Bibliographic Details
Main Authors:	Huilai Zhang, Yaxiao Lu, Tingting Zhang, Qingpei Guan, Xiaoxuan Wang, Yixian Guo, Lanfang Li, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Wenchen Gong, Bin Meng, Xiubao Ren, Xianhuo Wang
Format:	Article
Language:	English
Published:	Wiley 2022-04-01
Series:	Clinical and Translational Medicine
Online Access:	https://doi.org/10.1002/ctm2.808

Similar Items

Hodgkin’s lymphoma: 2023 update on treatment
by: Sicong Zhang, et al.
Published: (2024-04-01)

m6A-Regulator Expression Signatures Identify a Subset of Follicular Lymphoma Harboring an Exhausted Tumor Microenvironment
by: Tingting Zhang, et al.
Published: (2022-06-01)

Clinical features and outcomes of patients with follicular lymphoma: A real-world study of 926 patients in China
by: Fenghua Gao, et al.
Published: (2022-09-01)

A retrospective analysis of mature T- and NK-cell lymphomas
by: Junlei Jia, et al.
Published: (2024-03-01)

Biomimetic black phosphorus quantum dots-based photothermal therapy combined with anti-PD-L1 treatment inhibits recurrence and metastasis in triple-negative breast cancer
by: Peiqi Zhao, et al.
Published: (2021-06-01)

Research Progress on Molecular Diagnosis and Individualized Treatment for Malignant Lymphoma
by: WANG Ganggang, et al.
Published: (2023-12-01)

P044: PIM kinases support protumoral and immunosuppressive phenotype and functions of macrophages in classical Hodgkin Lymphoma
by: Maciej Szydłowski, et al.
Published: (2022-10-01)

Role and mechanism of PIM family in the immune microenvironment of diffuse large B cell lymphoma
by: Changying Wang, et al.
Published: (2023-03-01)

1428 Characteristics and a novel clinical prognostic assessment of hepatitis B virus-related follicular lymphoma
by: Lihong Liu, et al.
Published: (2023-11-01)

PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma
by: Brault, L, et al.
Published: (2012)

PIM kinases are progression markers and emerging therapeutic targets in diffuse large B-cell lymphoma.
by: Brault, L, et al.
Published: (2012)

An overview of pim kinase as a target in multiple myeloma
by: Zhaoyun Liu, et al.
Published: (2023-05-01)

Multicenter validation of PIM3 and PIM2 in Brazilian pediatric intensive care units
by: Daniel Hilário Santos Genu, et al.
Published: (2022-12-01)

PRAP-PIM: A weight pattern reusing aware pruning method for ReRAM-based PIM DNN accelerators
by: Zhaoyan Shen, et al.
Published: (2023-06-01)

PIM : Perpustakaan Inti Masyarakat
by: Perpustakaan UGM, i-lib
Published: (2003)

PIM Kinases in Multiple Myeloma
by: Jian Wu, et al.
Published: (2021-08-01)

Development of CO2‐Philic Blended Membranes Using PIM–PI and PIM–PEG/PPG
by: Insu Jeong, et al.
Published: (2023-05-01)

miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma
by: Qian Fan, et al.
Published: (2016-11-01)

Product information and management systems (PIMS)
by: Nagesh, K. N.
Published: (2008)

BL-PIM: Varying the Burst Length to Realize the All-Bank Performance and Minimize the Multi-Workload Interference for in-DRAM PIM
by: Chang Hyun Kim, et al.
Published: (2023-01-01)

Simultaneous phenotypically distinct but clonally identical mucosa-associated lymphoid tissue and follicular lymphoma in a patient with Sjogren's syndrome.
by: Aiello, A, et al.
Published: (1999)

Structure and substrate specificity of the Pim-1 kinase.
by: Bullock, A, et al.
Published: (2005)

Structure and substrate specificity of the Pim-1 kinase
by: Bullock, A, et al.
Published: (2005)

The Role of PIM Kinases in Pediatric Solid Tumors
by: Janet Rae Julson, et al.
Published: (2022-07-01)

Pim Kinases: Important Regulators of Cardiovascular Disease
by: Sophie Nock, et al.
Published: (2023-07-01)

Targeting PIM Kinases to Improve the Efficacy of Immunotherapy
by: Amber N. Clements, et al.
Published: (2022-11-01)

Data envelopment analysis: Introduction & PIM software
by: Emrouznejad, Ali
Published: (2014)

Distinct and shared neuropsychiatric phenotypes in FTLD-tauopathies
by: Rachel Keszycki, et al.
Published: (2023-06-01)

Evaluasi kinerja Badan Diklat Departemen Dalam Negeri :: Studi kasus pelaksanaan Diklat PIM III dan PIM IV
by: , SETIYONO, et al.
Published: (2005)

PB1778: PAN-PIM KINASE INHIBITOR PIM447 SHOWS SUPERIOR ANTI-LEUKEMIC EFFECT IN ACUTE ERYTHROID LEUKEMIA
by: Chi-Yang Tseng, et al.
Published: (2023-08-01)

Protein Translation Inhibition is Involved in the Activity of the Pan-PIM Kinase Inhibitor PIM447 in Combination with Pomalidomide-Dexamethasone in Multiple Myeloma
by: Teresa Paíno, et al.
Published: (2020-09-01)

KSHV reactivation from latency requires Pim-1 and Pim-3 kinases to inactivate the latency-associated nuclear antigen LANA.
by: Fang Cheng, et al.
Published: (2009-03-01)

Combined BRAF and PIM1 inhibitory therapy for papillary thyroid carcinoma based on BRAFV600E regulation of PIM1: Synergistic effect and metabolic mechanisms
by: Qianqian Xu, et al.
Published: (2024-06-01)

PGD2 displays distinct effects in diffuse large B-cell lymphoma depending on different concentrations
by: Shunfeng Hu, et al.
Published: (2023-02-01)

Targeting Echinococcus multilocularis PIM kinase for improving anti-parasitic chemotherapy.
by: Akito Koike, et al.
Published: (2022-10-01)

Transformation From CIM to PIM: a Systematic Mapping
by: Nemury Silega, et al.
Published: (2022-01-01)

AS INTERVENÇÕES DO PIM COMO OBJETO DE ANÁLISE
by: Fernanda Dias Almeida, et al.
Published: (2021-11-01)

Aligned Boron Nitride studies using HiPIMS
by: Lim, Nicholas Jian Chao
Published: (2019)

InSAR- and PIM-Based Inclined Goaf Determination for Illegal Mining Detection
by: Yuanping Xia, et al.
Published: (2020-11-01)

A Coupled Hydrologic–Hydraulic Model (XAJ–HiPIMS) for Flood Simulation
by: Yueling Wang, et al.
Published: (2020-05-01)